Numerous commensal bacteria present in the gut microbiota produce short chain fatty acids (SCFA’s) particularly acetate, butyrate and propionate. These SCFA’s have been associated with several biological effects upon host. Growing evidence suggests that specific microbes such as Faecalibacterium prausnitzii

In an article published online on June 24, 2014 in the Journal of Clinical Investigation, Zhongyi Chen and Lilu Guo, from the Vanderbilt University, Nashville, Tennessee, USA, showed that the administration of a modified bacteria expressing therapeutic factors in the gut microbiota could reduce

Prof. Patrice Cani, of Belgium’s Université catholique de Louvain, is involved in the Metabolism and Nutrition research group of the Louvain Drug Research Institute. He investigates the role of the gut microbiota in the development of metabolic disorders: obesity, type

#GMFH2014 INTERVIEWS: PROF. MAX NIEUWDORP

20 May 2014

by GMFH Editing Team

Following our video series from the Gut Microbiota for Health World Summit 2014, here is the interview of Prof. Max Nieuwdorp on the connection between metabolic syndrome and obesity to the gut microbiota.     https://www.gutmicrobiotaforhealth.com/videos/gmfh2014-interviews/Max-Nieuwdorp.mp4

After a residency in Internal Medicine and fellowship in Endocrinology at the AMC-UvA and a postdoctoral fellowship on glycobiology at UC San Diego (prof. Jeff Esko, department of Cellular and Molecular Medicine), Dr Nieuwdorp started his own translational research group